Headshot of Gaelle Chapuis.

Gaëlle Chapuis

Technical manager
International Brain Laboratory

Gaëlle Chapuis is a technical manager responsible for overseeing the activities of the International Brain Laboratory (IBL), a global consortium of 21 institutions and more than 75 people, aimed at understanding how brain activity patterns lead to decision-making. Chapuis is based at the University of Geneva and supervises a team of engineers deployed in five countries. Her group provides support to scientists, creating professionalized workflows that are adopted at a large scale. She also supervises the outreach efforts of the consortium. So far, more than 40 research projects in and outside the IBL have benefited from these technologies and organizational developments.

After earning a B.Sc. in microengineering at EPFL, Chapuis pursued an M.Sc. in biomedical engineering with a specialization in neurotechnology at Imperial College London. She then undertook several research projects in the field of sensory neuroscience at EPFL, the University of California, San Francisco and University College London before completing a Ph.D. at Imperial College London in the laboratory of Paul Chadderton.

Explore more from The Transmitter

Research image of developing axons in the fly brain.

How developing neurons simplify their search for a synaptic mate

Streamlining the problem from 3D to 1D eases the expedition—a strategy the study investigators deployed to rewire an olfactory circuit in flies.

By Calli McMurray
6 June 2025 | 6 min read
Distorted floppy discs.

NIH autism database announcement raises concerns among researchers

The U.S. National Institutes of Health announced a plan to pour $50 million into data science projects intended to investigate the condition’s causes, but the initiative’s short timeline and other atypicalities have prompted questions.

By Angie Voyles Askham
5 June 2025 | 5 min read
Image of alpha-synuclein filaments in the brain.

Large study links autism to Parkinson’s disease

Autistic adults appear to be prone to an early-onset form of Parkinson’s, according to a long-term study that tracked 2.2 million people in Sweden.

By Charles Q. Choi
5 June 2025 | 4 min read